- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Buzz
- Twitter: EW
- Twitter: $EW
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
EW Market Currents
more »
-
May 2 Edwards Lifesciences (EW +0.9%) shrugs off this mornings weakness after the Centers for Medicare & Medical Services announced it will cover Transcatheter Aortic Valve Replacement procedures for the treatment of symptomatic aortic valve stenosis, for which EW's Sapien is a marquee product. Separately, Wells Fargo ups the shares to Outperform on the news.
Comment![Healthcare]
EW in Focus
more »
EW Related Articles
more »
EW News
more »
-
at MarketWatch.com (Apr 25, 2012)
-
at MarketWatch.com (Apr 25, 2012)
-
at MarketWatch.com (Apr 25, 2012)
-
at MarketWatch.com (Apr 21, 2012)
-
at CNBC.com (Mar 26, 2012)
EW Press Releases and Filings
more »
-
Marketwire (May 17, 2012)
-
Marketwire (May 7, 2012)
-
Marketwire (May 3, 2012)
-
Marketwire (May 2, 2012)
-
Marketwire (May 2, 2012)
EW Latest Transcript
more »
EW Cramer
more »
EW Instablog posts
more »
EW vs. ETF Alternatives
Company Description
Edwards Lifesciences Corporation is a global leader in products and technologies designed to treat advanced cardiovascular disease. The Company is focused specifically on technologies that treat structural heart disease and critically ill patients.
Cardiovascular disease is the number-one... More